ADMA Biologics
ADMA
#3367
Rank
NZ$7.47 B
Marketcap
NZ$31.31
Share price
-0.66%
Change (1 day)
-5.64%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: NZ$7.47 Billion

As of January 2026 ADMA Biologics has a market cap of NZ$7.47 Billion. This makes ADMA Biologics the world's 3367th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$7.47 B-5.95%
2025NZ$7.94 B8.61%
2024NZ$7.31 B352.87%
2023NZ$1.61 B19.64%
2022NZ$1.34 B233.97%
2021NZ$0.40 B58.19%
2020NZ$0.25 B-27.47%
2019NZ$0.35 B113.32%
2018NZ$0.16 B-19.37%
2017NZ$0.20 B115.03%
2016NZ$95.25 M-24.59%
2015NZ$0.12 B-4.64%
2014NZ$0.13 B50.2%
2013NZ$88.19 M

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of ADMA Biologics was reported to be:

NZ$7.45 Billion
by Nasdaq info icon info icon
NZ$7.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
NZ$2.06 B-72.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$16.37 B 119.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$80.37 M-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA